Skip to main content
. 2020 Nov 10;10(11):1532. doi: 10.3390/biom10111532

Figure 7.

Figure 7

Effects of magnoflorine (MGN) on the cell cycle progression in NCIH1299 lung (A), MDA-MB-468 breast (B), T98G glioma (C), and TE671 rhabdomyosarcoma (D) cancer cells. Cancer cell lines were cultivated for 48 h with different doses of magnoflorine (5–10 mg/mL) and analyzed by flow cytometry. The results are depicted as means ± SD, n = 9 from three separate experiments.